Skip to main content
Signal8

Desai Neil

SEC insider (Form 3/4/5 filer). CIK 0001878692. Director at Whitehawk Therapeutics, Inc. (WHWK). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in MORRISTOWN, NJ.

Companies Desai Neil has filed insider reports for

  • Whitehawk Therapeutics, Inc. (WHWK): Director
Desai Neil profile photo

Desai Neil

CIK: 0001878692

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Whitehawk Therapeutics, Inc. logo
WHWK

Whitehawk Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Whitehawk Therapeutics, Inc. logo
    WHWK

    Whitehawk Therapeutics, Inc.

    Jun 12, 2026
    Award

    Stock Option (right to buy)

    Direct
    38K shares-
  • Whitehawk Therapeutics, Inc. logo
    WHWK

    Whitehawk Therapeutics, Inc.

    Jun 12, 2025
    Award

    Stock Option (right to buy)

    Direct
    40K shares-
  • Aadi Bioscience, Inc. logo
    AADI

    Aadi Bioscience, Inc.

    Sep 3, 2024
    Sale
    Indirect
    40K shares at avg. $1.71$68K

1-3 of 3